Coherus Oncology (CHRS) Construction in Progress (2015)
Coherus Oncology (CHRS) posted Construction in Progress of $2.2 million for Q3 2015.
Coherus Oncology (CHRS) Construction in Progress (2015) Analysis & Trends
Coherus Oncology has reported Construction in Progress for 1 years, with the latest figure at $2.2 million in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn | 152.67 Mn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - | - |
| 10 | Coherus Oncology | 215.97 Mn | 110.66 Mn | 10.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 2.20 Mn |